electroCore (ECOR) Projected to Post Earnings on Wednesday

electroCore (NASDAQ:ECOR) is projected to announce its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect electroCore to post earnings of ($0.35) per share and revenue of $9.0930 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, March 19, 2026 at 4:30 PM ET.

electroCore Stock Down 3.1%

Shares of ECOR opened at $6.64 on Tuesday. electroCore has a 52-week low of $4.16 and a 52-week high of $14.01. The stock has a fifty day simple moving average of $6.32 and a two-hundred day simple moving average of $5.50. The company has a market capitalization of $53.12 million, a PE ratio of -3.88 and a beta of 0.48.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC purchased a new position in shares of electroCore in the 1st quarter valued at about $153,000. Two Sigma Investments LP increased its stake in electroCore by 20.8% in the third quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after purchasing an additional 4,231 shares during the last quarter. Jane Street Group LLC raised its holdings in electroCore by 114.4% during the first quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after purchasing an additional 19,599 shares in the last quarter. DRW Securities LLC purchased a new stake in shares of electroCore during the 4th quarter worth approximately $264,000. Finally, NewEdge Advisors LLC lifted its position in shares of electroCore by 857.9% during the 1st quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock worth $1,083,000 after buying an additional 145,047 shares during the last quarter. Institutional investors and hedge funds own 26.74% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Zacks Research cut electroCore from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 28th. Brookline Capital Acquisition raised shares of electroCore to a “strong-buy” rating in a research report on Tuesday, February 3rd. Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a research note on Monday, December 29th. Finally, HC Wainwright reduced their price objective on electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a research note on Monday, January 26th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $22.00.

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.